Apotheken
|
Hôpital
|
Interactions
|
LiMA
|
Médecin
|
Médicaments
|
Services
|
T. de l'Autorisation
Retour à l'accueil
<
Liste pour "Kliogest N" (53)
–
Triage d'après Concentration, Taille et Prix
Comparaison des prix
Comparaison des prix et Composant
Nom de marque
Composant
Zulassungsinhaber
Application
Interaction
Effet indésirable
#-Swissmedic (5 chiffres)
Pharmacode
Préparation
Taille des prés.
PEF
PP
QP
CQ
Composition
Titulaire de l'aut.
Cat.
Qu'est-ce que c'est le code ATC?
Index ATC
(Codice) 44 Spécialités
DDD-OMS
L
IPro
V/S
Infanrix DTPa-IPV
20.20
38.40
10%
8 Principes actifs
GlaxoSmithKline AG
B / LS
FB
G
L
IPro
V/S
Engerix-B 20
23.66
42.15
10%
Suspension injectable: Hepatitidis b viri Antigenum Adnr 20 µg/ml
GlaxoSmithKline AG
B / LS
FB
G
IPro
IPat
Casgevy 4-13 x 10e6
cells/ml
DDP
DDP
N.O.
Vertex
Pharmaceuticals (CH)
GmbH
A
FB
G
IPro
IPat
Ebvallo
DDP
DDP
N.O.
Pierre Fabre Pharma SA
A
FB
G
IPro
IPat
BILAXIN Ophta 6 mg / ml
5 ml
DDP
DDP
N.O.
Collyre: Bilastinum 6 mg/ml
A. Menarini GmbH
D
FB
G
IPro
V/S
Engerix-B 20
10
DDP
DDP
N.O.
Suspension injectable: Hepatitidis b viri Antigenum Adnr 20 µg/ml
GlaxoSmithKline AG
B
FB
G
IPro
IPat
Imodium
‐
P
-
C
20 Gélule(s)
3.87
6.85
40%
Capsules: Loperamidi Hydrochloridum 2 mg
JNTL Consumer Health II
(Switzerland) GmbH
D / LS / SO
FB
G
IPro
IPat
Imodium
-
C
60 Gélule(s)
9.40
26.60
40%
Capsules: Loperamidi Hydrochloridum 2 mg
JNTL Consumer Health II
(Switzerland) GmbH
B / LS / SO
FB
G
IPro
IPat
Incruse Ellipta
30 unidose(s)
34.64
54.10
10%
Poudre pour inhalation: Umeclidinium 62.5 µg
GlaxoSmithKline AG
B / LS
FB
G
IPro
IPat
Incruse Ellipta
3 x 30 unidose(s)
103.00
128.45
10%
Poudre pour inhalation: Umeclidinium 62.5 µg
GlaxoSmithKline AG
B / LS
FB
G
L
IPro
V/S
Hiberix
Set(s)
16.16
34.00
10%
Haemophilus Influenzae b Polysaccharida (Prp) 10 mcg
GlaxoSmithKline AG
B / LS
FB
G
L
IPro
IPat
Microlax
4 x 5 ml
4.15
7.65
10%
Lavement: 3 Principes actifs
JNTL Consumer Health II
(Switzerland) GmbH
D / LS
FB
G
L
IPro
IPat
Microlax
12 x 5 ml
12.45
23.00
10%
Lavement: 3 Principes actifs
JNTL Consumer Health II
(Switzerland) GmbH
D / LS / LPPA
FB
G
L
IPro
IPat
Microlax
50 x 5 ml
51.88
95.80
10%
Lavement: 3 Principes actifs
JNTL Consumer Health II
(Switzerland) GmbH
D / LS / LPPA
FB
G
L
IPro
Vegzelma 100 mg/4 ml
257.57
296.55
10%
Concentré pour perfusion: Bevacizumabum 100mg / 4ml
iQone Healthcare
Switzerland SA
A / LS
FB
G
L
IPro
Vegzelma 400 mg/16 ml
962.84
1063.55
10%
Concentré pour perfusion: Bevacizumabum 400mg / 16ml
iQone Healthcare
Switzerland SA
A / LS
FB
G
L
IPro
IPat
D3 VitaCaps 24,000 IU
(600 μg)
6
7.65
17.55
10%
Capsules molles: Cholecalciferolum 600 µg
Pierre Fabre Pharma SA
B / LS
FB
G
L
IPro
IPat
Vitamin D3 Sandoz eco
1000 I.E.
30
1.68
3.10
10%
Capsules molles: Cholecalciferolum 1000 UI
Sandoz
Pharmaceuticals AG
● 
D / LS
FB
G
L
IPro
IPat
Vitamin D3 Sandoz eco
1000 I.E.
90
5.04
9.30
10%
Capsules molles: Cholecalciferolum 1000 UI
Sandoz
Pharmaceuticals AG
● 
D / LS
FB
G
L
IPro
IPat
Vitamin D3 Sandoz eco
3200 I.E.
30
5.38
15.10
10%
Capsules molles: Cholecalciferolum 3200 UI
Sandoz
Pharmaceuticals AG
● 
B / LS
FB
G
L
IPro
IPat
Vitamin D3 Sandoz eco
3200 I.E.
90
16.13
33.95
10%
Capsules molles: Cholecalciferolum 3200 UI
Sandoz
Pharmaceuticals AG
● 
B / LS
FB
G
L
IPro
IPat
Vitamin D3 Sandoz eco
25000 I.E.
4
5.60
15.30
10%
Capsules molles: Cholecalciferolum 25000 UI
Sandoz
Pharmaceuticals AG
B / LS
FB
G
IPro
IPat
Arnuity Ellipta 90 mcg
30 unidose(s)
15.60
33.40
10%
Einzeldosiertes Pulver zur Inhalation: Fluticasoni Furoas 90 µg
GlaxoSmithKline AG
B / LS
FB
G
IPro
IPat
Arnuity Ellipta 90 mcg
3 x 30
46.80
67.30
10%
Einzeldosiertes Pulver zur Inhalation: Fluticasoni Furoas 90 µg
GlaxoSmithKline AG
B / LS
FB
G
IPro
IPat
Arnuity Ellipta 182 mcg
30 unidose(s)
25.58
44.25
10%
Einzeldosiertes Pulver zur Inhalation: Fluticasoni Furoas 182 µg
GlaxoSmithKline AG
B / LS
FB
G
IPro
IPat
Arnuity Ellipta 182 mcg
3 x 30
76.74
99.90
10%
Einzeldosiertes Pulver zur Inhalation: Fluticasoni Furoas 182 µg
GlaxoSmithKline AG
B / LS
FB
G
L
IPro
PP
Herceptin subkutan
600mg/5ml
1484.04
1630.40
10%
Lösung zur subkutanen Injektion: Trastuzumabum 600mg / 5ml
Roche Pharma
(Schweiz) AG
A / LS
FB
G
L
IPro
Ogivri 150 mg
456.84
513.25
10%
Pulver für ein Konzentrat zur Herstellung einer Infusionslösung: Trastuzumabum 150 mg
Medius AG
A / LS
FB
G
L
IPro
V/S
Menveo
Kombipackung(en)
31.69
50.90
10%
Pulver und Lösung (Durchstechflaschen): Oligosaccharida Neisseriae Meningitidis A 10 µg
Pulver und Lösung (Durchstechflaschen): 3 Principes actifs
GlaxoSmithKline AG
B / LS
FB
G
L
IPro
V/S
Menveo
5 Kombipackung(en)
158.45
37.75
10%
Pulver und Lösung (Durchstechflaschen): Oligosaccharida Neisseriae Meningitidis A 10 µg
Pulver und Lösung (Durchstechflaschen): 3 Principes actifs
GlaxoSmithKline AG
B / LS
FB
G
IPro
IPat
Imodium lingual akut
10
DDP
DDP
N.O.
Comprimés orodispersibles: Loperamidi Hydrochloridum 2 mg
JNTL Consumer Health II
(Switzerland) GmbH
D
FB
G
IPro
IPat
Imodium lingual akut
12
DDP
DDP
N.O.
Comprimés orodispersibles: Loperamidi Hydrochloridum 2 mg
JNTL Consumer Health II
(Switzerland) GmbH
D
FB
G
IPro
IPat
Nicorette Microtab
Original-Aroma
100 Comprimé(s)
DDP
DDP
N.O.
Comprimés sublinguaux: Nicotinum 2 mg
JNTL Consumer Health II
(Switzerland) GmbH
D / LPPA
FB
G
IPro
IPat
D3 VitaCaps 24,000 IU
(600 μg)
4
DDP
DDP
N.O.
Capsules molles: Cholecalciferolum 600 µg
Pierre Fabre Pharma SA
B
FB
G
IPro
IPat
D3 VitaCaps 24,000 IU
(600 μg)
8
DDP
DDP
N.O.
Capsules molles: Cholecalciferolum 600 µg
Pierre Fabre Pharma SA
B
FB
G
IPro
IPat
D3 VitaCaps 24,000 IU
(600 μg)
12
DDP
DDP
N.O.
Capsules molles: Cholecalciferolum 600 µg
Pierre Fabre Pharma SA
B
FB
G
IPro
IPat
Vitamin D3 Sandoz eco
25000 I.E.
8
DDP
DDP
N.O.
Capsules molles: Cholecalciferolum 25000 UI
Sandoz
Pharmaceuticals AG
B
FB
G
IPro
IPat
Vitamin D3 Sandoz eco
25000 I.E.
12
DDP
DDP
N.O.
Capsules molles: Cholecalciferolum 25000 UI
Sandoz
Pharmaceuticals AG
B
FB
G
IPro
Arnuity Ellipta 46 mcg
30
DDP
DDP
N.O.
Einzeldosiertes Pulver zur Inhalation: Fluticasoni Furoas 46 µg
GlaxoSmithKline AG
B
FB
G
IPro
IPat
Regaine 2 %
60 ml
DDP
DDP
N.O.
Solution: Minoxidilum 20 mg/ml
JNTL Consumer Health II
(Switzerland) GmbH
D / LPPA
FB
G
IPro
IPat
Regaine 2 %
3 x 60 ml
DDP
DDP
N.O.
Solution: Minoxidilum 20 mg/ml
JNTL Consumer Health II
(Switzerland) GmbH
D / LPPA
FB
G
IPro
IPat
Regaine 5 %
60 ml
DDP
DDP
N.O.
Solution: Minoxidilum 50 mg/ml
JNTL Consumer Health II
(Switzerland) GmbH
D / LPPA
FB
G
IPro
IPat
Regaine 5 %
3 x 60 ml
DDP
DDP
N.O.
Solution: Minoxidilum 50 mg/ml
JNTL Consumer Health II
(Switzerland) GmbH
D / LPPA
FB
G
IPro
Mylotarg 5 mg
DDP
DDP
N.O.
Pulver für ein Konzentrat zur Herstellung einer Infusionslösung: Gemtuzumabum Ozogamicinum 5 mg
Pfizer AG
A
FB
G
Norethisteron und Estrogen (G03FA01) 9 Spécialités
DDD-OMS
DrugBank.ca
IPro
IPat
Activelle
28 Comprimé(s)
8.38
25.55
10%
Comprimés filmés: 2 Principes actifs
Novo Nordisk Pharma AG
B / LS
FB
G
IPro
IPat
Kliogest N
28 Comprimé(s)
8.20
25.35
10%
Comprimés filmés: 2 Principes actifs
Novo Nordisk Pharma AG
B / LS
FB
G
IPro
IPat
Systen Conti
8 pansement(s)
12.04
29.50
10%
patch transdermique: 2 Principes actifs
Labatec Pharma SA
B / LS
FB
G
IPro
IPat
Systen Conti
24 pansement(s)
31.28
50.45
10%
patch transdermique: 2 Principes actifs
Labatec Pharma SA
B / LS
FB
G
IPro
IPat
Systen Sequi
8 pansement(s)
7.66
17.55
10%
patch transdermique (emballage combiné): Estradiolum 3.1 mg
patch transdermique (emballage combiné): 2 Principes actifs
Labatec Pharma SA
B / LS
FB
G
IPro
IPat
Estalis 50/140
8 pansement(s)
10.55
27.90
N.O.
Timbre transdermique: 2 Principes actifs
Sandoz
Pharmaceuticals AG
B
FB
G
IPro
IPat
Estalis 50/140
24 pansement(s)
27.46
46.30
N.O.
Timbre transdermique: 2 Principes actifs
Sandoz
Pharmaceuticals AG
B
FB
G
IPro
IPat
Estalis 50/250
8 pansement(s)
11.63
29.05
N.O.
Timbre transdermique: 2 Principes actifs
Sandoz
Pharmaceuticals AG
B
FB
G
IPro
IPat
Estalis 50/250
24 pansement(s)
32.44
51.70
N.O.
Timbre transdermique: 2 Principes actifs
Sandoz
Pharmaceuticals AG
B
FB
G
Classification ATC
|
Médicaments de A à Z
|
Nouveaux enregistrements
2025
©ywesee GmbH
Einstellungen
|
Aide
|
FAQ
|
Identification
|
Contact
|
Home